Analysis of the Application of Laparoscopic Surgery in Benign Gynecological Tumors

Abstract

Objective: To explore and analyze the application of laparoscopic surgery in benign gynecological tumors. Methods: Forty patients with benign gynecological tumors admitted to the Department of Gynecology in Gaoyou People’s Hospital from August 2022 to August 2023 were selected as research subjects. They were divided into a research group (n = 20) and a reference group (n = 20) using the double-blind method. The research group received laparoscopic surgery, while the reference group underwent conventional treatment. Immune indicators, inflammatory factor levels, surgical outcomes, and test indicators were compared between the groups. Results: Before surgery, immune indicators such as CD8+, CD4+, CD4+/CD8+, and CD3+ were comparable between the groups (P > 0.05). Post-surgery, the research group exhibited better results in immune indicators compared to the reference group (P < 0.05). Before treatment, levels of inflammatory factors including IL-4, IL-2, and TNF-α showed no statistically significant difference (P > 0.05). However, after surgery, the research group demonstrated significantly better outcomes in terms of inflammatory factors compared to the reference group (P < 0.05). Surgical outcomes such as blood loss, postoperative recovery time, hospitalization time, anal exhaust time, and drainage tube removal time in the research group were significantly better than those in the reference group (P < 0.05). Before surgery, test indicators such as hemoglobin, C-reactive protein, and albumin were similar between the groups (P > 0.05). After surgery, the research group showed significantly better outcomes in test indicators compared to the reference group (P < 0.05). Conclusion: Laparoscopic surgery demonstrates a notable curative effect on benign gynecological tumors, warranting widespread application and promotion.